City of Hope: Promising Phase 1 Clinical Trial Results: Use of Sotorasib in Patients With Solid Tumors
September 20, 2020
September 20, 2020
DUARTE, California, Sept. 20 (TNSRes) -- City of Hope issued the following news release:
A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City of Hope and other renowned comprehensive cancer centers.
The multisite clinical trial included 129 metastatic cancer patients who had received an average of three p . . .
A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City of Hope and other renowned comprehensive cancer centers.
The multisite clinical trial included 129 metastatic cancer patients who had received an average of three p . . .